| Literature DB >> 32184572 |
Rob A B Oostendorp1,2,3,4, J W Hans Elvers5,6, Emiel van Trijffel7,8, Geert M Rutten9,10, Gwendolyne G M Scholten-Peeters11, Marcel Heijmans4, Erik Hendriks12,13, Emilia Mikolajewska14,15, Margot De Kooning3,16, Marjan Laekeman17, Jo Nijs3,16, Nathalie Roussel18, Han Samwel19.
Abstract
BACKGROUND: Quality indicators (QIs) are measurable elements of practice performance and may relate to context, process, outcome and structure. A valid set of QIs have been developed, reflecting the clinical reasoning used in primary care physiotherapy for patients with whiplash-associated disorders (WAD). Donabedian's model postulates relationships between the constructs of quality of care, acting in a virtuous circle. AIM: To explore the relative strengths of the relationships between context, process, and outcome indicators in the assessment of primary care physiotherapy in patients with WAD.Entities:
Keywords: collected data; healthcare quality indicators; outcome and process assessment; physiotherapy; whiplash injuries
Year: 2020 PMID: 32184572 PMCID: PMC7060032 DOI: 10.2147/PPA.S234800
Source DB: PubMed Journal: Patient Prefer Adherence ISSN: 1177-889X Impact factor: 2.711
Overview of Context (n=9), Process (n=9), Outcome (n=7) and Structure (n=2) Indicators for Physiotherapy in Patients with Whiplash-Associated Disorders (WAD)
| I. Context indicators |
| Indicator 1: Patient’s information |
| Indicator 2: Patient’s request for care |
| Indicator 3: Patient’s sociodemographic characteristics |
| Indicator 4: Accident-related information |
| Indicator 5: Pre-existent functioning |
| Indicator 6: Pre-existent health status before injury |
| Indicator 7: Previous diagnostics and treatment |
| Indicator 8: Current health status |
| Indicator 9: Recovery since accident and prognostic factors |
| II. Process indicators |
| Indicator 10: Objectives of examination |
| Indicator 11: Musculoskeletal examination |
| Indicator 12: Neurological examination |
| Indicator 13: Oto-neurological examination (since 2000) |
| Indicator 14: Psychological examination |
| Indicator 15: Analysis and conclusion of diagnostic process |
| Indicator 16: Treatment goals |
| Indicator 17: Treatment (manual) physiotherapy modalities |
| Indicator 18: Side effects |
| III. Outcome indicators |
| Indicator 19: Intermediate evaluation |
| Indicator 20: Subjective final evaluation |
| Indicator 21: Objective final evaluation |
| Indicator 22: Global perceived effect |
| Indicator 23: Treatment duration and number of sessions |
| Indicator 24: Reason for discharge |
| Indicator 25: Aftercare |
| IV. Structure indicators |
| Indicator 26: Physiotherapy practice |
| Indicator 27: Physiotherapist’s sociodemographic characteristics |
Selected Variables per Context Indicator in Patients with Whiplash-Associated Disorders (WAD)
| Description (n= Number of Selected or Non-Selected Variables per Indicator) Detailed Information: Supplementary File 1. | Total |
|---|---|
| N=810 | |
| Indicator 1: Patient’s information (non-selected: n=2) | |
| Indicator 2: Request for care (non-selected: n=1) | |
| Indicator 3: Patient’s sociodemographic characteristics (non-selected: n=4) | |
| Indicator 4: Accident-related information (non-selected: n=4) | |
| Indicator 5: Pre-existent functioning (non-selected: n=1) | |
| Indicator 6: Pre-existent health status before injury (non-selected: n=4) | |
| Indicator 7: Previous diagnostics and treatment (selected: n=1; non-selected: n=4) | |
| Cervical soft collar (yes) | 515 (63.6) |
Weeks (mean; SD) | 3.9 (2.0) |
| Indicator 8: Current health status (selected: n=3; non-selected: n=3) | |
| Current pain medication | 242 (29.9) |
| Current number and type of complaints | |
≤3: neck pain, stiffness, decreased ROM# | 6 (0.7) |
4–6: + dizziness, headache and tinnitus | 374 (46.2) |
7–9: + cognitive impairments | 424 (52.3) |
>9: + rest | 6 (0.7) |
| Current type of signs and symptoms | |
Neck symptoms (pain, stiffness and tenderness) | 114 (14.1) |
Neck symptoms + decreased ROM# | 559 (69.0) |
Neck symptoms + decreased ROM# + neurological signs | 137 (16.9) |
| Indicator 9: Recovery since accident and previous prognostic factors (selected: n=5; non-selected n=2) | |
| Estimation of previous coping | |
Active | 329 (40.7) |
Inestimable | 38 (3.7) |
Passive | 443 (54.7) |
| Estimation of previous fear avoidance | |
No | 146 (18.2) |
Inestimable | 197 (24.3) |
Yes | 467 (57.7) |
| Classification Whiplash-Associated Disorders (WAD)## | |
WAD 0 | - |
WAD 1 | 123 (15.2) |
WAD 2 | 555 (68.5) |
WAD 3 | 132 (16.3) |
WAD 4 | - |
| Time phase since accident | |
>7 days 1 – 3 weeks | 19 (2.3) |
4 – 6 weeks | 192 (23.7) |
7 –12 weeks | 183 (22.6) |
3 – 6 months | 155 (19.1) |
>6 months | 121 (14.9) |
| Determination of prognostic health profile### | |
Profile A | 184 (22.7) |
Profile B | 350 (43.2) |
Profile C | 276 (34.1) |
Notes: #Classification WAD: Whiplash-Associated Disorders: WAD 0: no neck symptoms, no physical sign(s); WAD 1: neck pain, stiffness or tenderness only, no physical sign(s); WAD 2: neck symptoms and musculoskeletal sign(s); WAD 3: neck symptoms and neurological sign(s); WAD 4: neck symptoms and fracture or dislocation. ##Prognostic Health Profile: Profile A: normal recovery, low intensity of pain, decreasing pain, increasing activities, active coping, no fear avoidance; Profile B: inestimable recovery, middle intensity of pain, persistent pain, persistent activity limitations, inestimable coping, inestimable fear avoidance; - Profile C: delayed recovery, high intensity of pain, increasing pain, decreasing activities, passive coping, fear avoidance. Adapted from Oostendorp RA, Elvers H, van Trijffel E, et al. Has the quality of physiotherapy care in patients with Whiplash-associated disorders (WAD) improved over time? A retrospective study using routinely collected data and quality indicators. Patient Prefer Adherence. 2018;12:2291–2308. Copyright © 2018 Oostendorp et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at: and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.38
Abbreviations: SD, standard deviation; ROM, range of motion.
Selected Variables per Process Indicator in Patients with Whiplash-Associated Disorders (WAD)
| Description (n= Number of Selected or Non-Selected Variables per Indicator) Detailed Information: Supplementary File 2. | Total |
|---|---|
| Indicator 10: Objectives of examination (non-selected: n=4) | |
| Indicator 11: Musculoskeletal examination (non-selected: n=4) | |
| Indicator 12: Neurological examination (non-selected: n=4) | |
| Indicator 13: Oto-neurological examination (since 2000; n=621) (non-selected: n=4) | |
| Indicator 14: Psychological examination (selected: n=2; non-selected: n=1) | |
| Pain Coping Inventory (PCI) (since 2002; n=523) | |
Active coping | |
| Score 12-48 (mean: 95% CI)) | 27.1 (26.6-27.6) |
| Cutoff point: ≥ 24
Passive coping | 396 (75.7) |
| Score 21-84 (mean; 95% CI) | 54.2 (53.1-55.3) |
| Cut off point : ≥42 | 416 (79.5) |
| Fear Avoidance Beliefs Questionnaire Dutch Version (FABQ-DV) (since 2002; n=523) ## FABQ-DV-Activities (n=523) | |
| Score: 0-24 (mean; 95% CI) | 16.0 (15.7-16.3) |
| Cutoff point >15 | 346 (66.2) |
FABQ—DV-Work (n=354) | |
| Score: 0-42 (mean; 95% CI) | 29.3 (28.5-30.1) |
| Cutoff point >34 | 135 (38.1) |
| Indicator 15: Conclusion diagnostic process (non-selected: n=2) | |
| Indicator 16: Treatment goals per phase after WAD-related accident### (selected: n=8); non-selected: n=3) | |
| ● Phase 1: <7 days; n=19; yes | 11 (57.9) |
| ● Phase 2: 1–3 weeks; n=140; yes | 82 (58.6) |
| ● Phase 3a: 4–6 weeks; n=17; yes | 12 (70.6) |
| ● Phase 3b: 4–6 weeks; n=175; yes | 96 (54.9) |
| ● Phase 4a: 7–12 weeks; n=8; yes | 5 (62.5) |
| ● Phase 4b: 7–12 weeks; n=175; yes | 124 (70.9) |
| ● Phase 5: 3–6 months; n=155; yes | 128 (82.6) |
| ● Phase 6: >6 months; n=121; yes | 71 (58.7) |
| Indicator 17: Treatment physiotherapy modalities per phase in agreement with treatment goals#### (selected: n=8) | |
| ● Phase 1: <7 days; n=11; yes | 9 (81.8) |
| ● Phase 2: 1–3 weeks; n=82; yes | 67 (81.7) |
| ● Phase 3a: 4–6 weeks; n=12; yes | 10 (83.3) |
| ● Phase 3b: 4–6 weeks; n=96; yes | 80 (83.3) |
| ● Phase 4a: 7–12 weeks; n=5; yes | 3 (60.0) |
| ● Phase 4b: 7–12 weeks; n=124; yes | 107 (86.3) |
| ● Phase 5: 3–6 months; n=128; yes | 110 (85.9) |
| ● Phase 6: >6 months; n=71; yes | 56 (78.9) |
| Indicator 18: Side effects (non-selected: n=1) | |
Notes: 95% CI = confidence interval; #Pain Coping Inventory (PCI): 33-item questionnaire measuring active coping (PCI-Active: 12 items [range score: 12–48]; ≥24 active coping); passive coping (PCI-P: 21 items [range score: 21–84]; ≥42 passive coping). Items are scored on a 4-point Likert scale ranging from 1 (hardly ever) to 4 (very often); ##Fear Avoidance Beliefs Questionnaire (FABQ: 16-item questionnaire) measuring fear-avoidance beliefs about physical activities (FABQ-Activities: 4 items [range score: 0–24]; >15 at risk for pain avoiding behavior); work-related activities (FABQ-Work: 7 items [range score: 0–42]; >34 at risk for no return to work). Items are scored on a 7-point Likert scale ranging from 0 (completely disagree) to 6 (completely agree). ###Phase-related treatment goals: Phase 1 (<7 days; acute; normal recovery; Profile A): reducing pain; providing information and explaining the consequences for functioning and underlying pain mechanisms; Phase 2 (1–3 weeks; acute; normal recovery; Profile A): see Phase 1 + improving neuromusculoskeletal functions; Phase 3a (4–6 weeks; sub-acute; inestimable recovery; Profile A): see Phase 2 + increasing activities and participation; Phase 3b (4–6 weeks; sub-chronic; delayed recovery; Profile B): explaining underlying pain mechanisms, improving active coping, decreasing fear avoidance, increasing physical load capacity, increasing activities and participation; Phase 4a (7–12 weeks; sub-acute; inestimable recovery; Profile A): see Phase 3a + minimizing delay in work participation; Phase 4b (7–12 weeks; sub-chronic; delayed recovery; Profile B): see Phase 3b; Phase 5 (3–6 months; chronic; no recovery; Profile C): see Phase 3b + changing pain behavior; Phase 6 (>6 months; chronic; no recovery; Profile C): see Phase 3b + 5. ####Phase-related physiotherapy treatment modalities in agreement with treatment goals (Classification of Physiotherapy Modalities). Phase 1: (<7 days): education, coaching, active exercise therapy, and, if indicated, cervical soft collar; Phase 2: (1–3 weeks): see Phase 1 + cervical soft collar (<2 weeks), massage therapy (<2 weeks); Phase 3a: (4–6 weeks): see Phase 1 + physical loading exercise therapy; Phase 3b: (4–6 weeks): pain education, exercise therapy based on cognitive and physical principles, and coaching; Phase 4a: (7–12 weeks): see Phase 3a + graded activity; Phase 4b: (7–12 weeks): see Phase 3b + graded exposure; Phase 5: (3–6 months): see Phase 4b; Phase 6 (>6 months): see Phase 5. Adapted from Oostendorp RA, Elvers H, van Trijffel E, et al. Has the quality of physiotherapy care in patients with Whiplash-associated disorders (WAD) improved over time? A retrospective study using routinely collected data and quality indicators. Patient Prefer Adherence. 2018;12:2291–2308. Copyright © 2018 Oostendorp et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at: and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (). By accessing the work you hereby accept the Terms. Noncommercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided he work is properly attributed.38
Selected Variables per Outcome Indicator in Patients with Whiplash-Associated Disorders (WAD)
| Description (n = Number of Selected or Non-Selected Variables per Indicator) Detailed Information: Supplementary File 4. | Total |
|---|---|
| Indicator 19: Intermediate evaluation (non-selected: n=4) | |
| Indicator 20: Subjective final evaluation (selected: n=2) | |
| Subjective evaluation | 810 (100) |
| Returned to work participation | |
Not employed | 228 (28.1) |
Employed with adaptations | 313 (38.6) |
Employed without adaptations | 184 (22.7) |
Retired | 85 (10.5) |
| Indicator 21: Objective final evaluation (selected: n=2) | |
| Pain intensity (since 2002; n=523; Visual Analogue Scale [VAS])● | |
Score 0-100 (mean; 95% CI) | 29.6 (28.4–30.7) |
≤30: functionally recovered | 310 (59.3) |
| Functioning (since 2002; n=523; Neck Disability Index [NDI]●● | |
Score 0-50 (mean;95% CI) | 15.9 (15.1–16.6) |
≤14: functionally recovered | 191 (36.5) |
| Indicator 22: Global Perceived Effect (selected: n=1) | |
| Evaluation by Global Perceived Effect (since 2002; n=523) (GPE: 1-6)●●● | |
Responders (1 + 2: Complete / much recovered and improved) | 241 (46.1) |
Non-responders (3 + 4 + 5 + 6: Slightly improved / worse) | 282 (53.9) |
| Indicator 23: Treatment duration and number of sessions (selected: n=2) | |
| Duration of treatment period
<1 month | - |
2–3 months | 280 (34.6) |
4–6 months | 501 (61.9) |
>6 months | 29 (3.6) |
| Number of treatment sessions | |
<5 | 2 (0.2) |
5–10 | 10 (1.2) |
11–15 | 329 (40.6) |
16–20 | 405 (50.0) |
>20 | 64 (7.9) |
| Indicator 24: Discharge (selected: n=1; non-selected: n=1) | |
| Reason for discharge | |
Maximal / optimal result | 241 (46.1) |
Minimal result | 267 (51.1) |
No result | 15 (2.9) |
| Indicator 25: Aftercare (non-selected: n=1) | |
Notes: ●Pain intensity: Visual Analogue Scale Pain (VAS-P); score 0 (no pain) – 100 (worst imaginable pain). ●●Functioning: Neck Disability Index (NDI); score 0 (no activity limitation) – 50 (maximal activity limitation). ●●●Global Perceived Effect (GPE): 1 (complete improved) to 6 (worse than ever); responders (1+2); non-responders (3+4+5+6). Adapted from Oostendorp RA, Elvers H, van Trijffel E, et al. Has the quality of physiotherapy care in patients with Whiplash-associated disorders (WAD) improved over time? A retrospective study using routinely collected data and quality indicators. Patient Prefer Adherence. 2018;12:2291–2308. Copyright © 2018 Oostendorp et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at: and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (). By accessing the work you hereby accept the Terms. Noncommercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided he work is properly attributed.38
Relationships Between Selected Context Variables and Selected Process Variables Expressed as Spearman Rank Correlation Coefficient#
| Context Variables | Process Variables – Treatment Goals●● per Phase After WAD-Related Accident● | |||||||
|---|---|---|---|---|---|---|---|---|
| Phase 1● | Phase 2● | Phase 3a● | Phase 3b● | Phase 4a● | Phase 4b● | Phase 5● | Phase 6● | |
| < 7 Days | 1–3 Weeks | 4–6 Weeks | 4–6 Weeks | 7–12 Weeks | 7–12 Weeks | 3–6 Months | >6 Months | |
| Previous cervical collar | − 0.31* | - | - | - | 0.42* | |||
| Current pain medication | − 0.31* | − 0.28* | - | 0.32* | 0.37* | |||
| Current complaints | - | - | - | - | - | |||
| Current signs and symptoms | - | - | - | - | - | |||
| Estimation of previous coping | − 0.53* | − 0.46* | 0.29* | 0.41* | 0.32* | |||
| Estimation of previous fear avoidance | − 0.50* | − 0.41* | 0.27* | 0.37* | 0.30* | |||
| Classification WAD●●● | - | - | - | - | - | |||
| Health profile●●●● | − 0.48* | − 0.53* | 0.33* | 0.43* | 0.38* | |||
Notes: #Spearman rank correlation: criterion: r >0.25 (minimum: fair). Spearman rank correlation: criterion: r≤0.25. Empty box: no statistics (n<20). *Statistical significance: p≤0.00. ●Phases after WAD-related accident: Phase 1: normal recovery (acute); Phase 2: normal recovery (acute); Phase 3a: inestimable recovery (sub-acute); Phase 3b: inestimable recovery (sub-chronic); Phase 4a: delayed recovery (sub-acute); Phase 4b: delayed recovery (sub-chronic); Phase 5: no recovery (chronic); Phase 6: no recovery (chronic). ●●Phase-related treatment goals: see legend Table 3. ●●●Classification WAD: see legend Table 2. ●●●●Prognostic health profile: see legend Table 2.
Relationships Between Selected Process Variables and Selected Outcome Variables Expressed as Spearman Rank Correlation Coefficient#
| Process Variables | Outcome Variables I–VIII● (n=810) | |||||||
|---|---|---|---|---|---|---|---|---|
| I | II | III | IV | V | VI | VII | VIII | |
| n=523 | n=523 | n=523 | ||||||
| PCI-active●● | – | – | − 0.50* | − 0.59* | – | – | – | – |
| PCI-passive●● | – | – | – | 0.33* | – | – | – | – |
| FABQ-DV- Activities●● | – | – | 0.49* | 0.51* | – | – | – | 0.26* |
| FABQ-DV-Work●● | – | – | 0.55* | 0.58* | – | – | – | – |
| Phase 1 (< 7 days)●●● | ||||||||
| Phase 2 (1–3 weeks)●●● | – | – | – | – | – | – | – | – |
| Phase 3a (4–6 weeks)●●● | ||||||||
| Phase 3b (4–6 weeks)●●● | – | – | – | – | – | – 0.29* | – 0.48* | – |
| Phase 4a (7–12 weeks)●●● | – | |||||||
| Phase 4b (7–12 weeks)●●● | – | – | – | – | – | – | – | – |
| Phase 5 (3–6 months)●●● | – | – | – | – | – | – | – | – |
| Phase 6 (> 6 months)●●● | – | – | – | – | – | – | – | – |
Notes: #Spearman rank correlation: criterion: r > 0.25 (minimum: fair). –Spearman rank correlation: criterion: r ≤ 0.25. Empty box: no statistics (n< 20). *Statistical significance: p ≤ 0.00. ●Outcome variables: see legend Tables 4 and 6. ●●Pain Coping Inventory (PCI: PCI-active and PCI-passive) and Fear Avoidance Beliefs Questionnaire (FABQ: FABQ-activities and FABQ-work): see legend Table 3. ●●●Phase-related treatment goals: see legend Table 3.
Relationships Between Selected Context Variables and Selected Outcome Variables Expressed as Spearman Rank Correlation Coefficient#
| Context Variables | Outcome Variables I–VIII● (n=810) | |||||||
|---|---|---|---|---|---|---|---|---|
| I | II | III | IV | V | VI | VII | VIII | |
| n=523 | n=523 | n=523 | ||||||
| Previous cervical collar | – | – | – | – | – | – | 0.26* | – |
| Previous pain medication | – | – | – | – | – | – | 0.32* | – |
| Current complaints | – | – | – | – | – | – | – | – |
| Current signs and symptoms | – | – | – | – | – | – | – | – |
| Estimation of previous coping | – | – | – | – | – | 0.30* | 0.48* | – |
| Estimation of previous fear avoidance | – | – | – | – | – | 0.29* | 0.46* | – |
| Classification WAD●● | – | – | – | – | – | – | – | – |
| Time since accident●●● | – | – | – | – | – | 0.31* | 0.55* | – |
| Health profile●●●● | – | – | – | – | – | 0.33* | 0.52* | – |
Notes: #Spearman rank correlation: criterion: r > 0.25 (minimum: fair). –Spearman rank correlation: criterion: r ≤ 0.25. *Statistical significance: p ≤ 0.00. ●Outcome variables (Legend see Table 4): I. Final subjective evaluation; II. Returned to work participation; III. Pain intensity (Visual Analogue Scale [VAS]); IV. Functioning (Neck Disability Index [NDI]); V. Global Perceived Effect (GPE); VI. Duration of treatment period; VII. Number of treatment sessions; VIII. Reason for discharge. ●●Classification WAD: see legend Table 2. ●●●Time since whiplash-related accident: see legend 5. ●●●●Health profile: see legend Table 2.